Previous close | 20.10 |
Open | 20.13 |
Bid | 20.18 x N/A |
Ask | 20.26 x N/A |
Day's range | 20.12 - 20.27 |
52-week range | 20.12 - 20.94 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 31 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
The latest investor updates on stocks that are trending on Wednesday.